Literature DB >> 17535272

Prevalence and clinical characteristics of immune thrombocytopenic purpura in a cohort of monoclonal gammopathy of uncertain significance.

Davide Rossi1, Lorenzo De Paoli, Silvia Franceschetti, Daniela Capello, Chiara Vendramin, Monia Lunghi, Annarita Conconi, Corrado Magnani, Gianluca Gaidano.   

Abstract

Monoclonal gammopathy of uncertain significance (MGUS) may become symptomatic for autoimmune manifestations. We report on the prevalence and clinical course of immune thrombocytopenic purpura (ITP) observed in a consecutive series of 228 MGUS patients. At MGUS diagnosis, ITP was determined in 6/228 cases, accounting for a prevalence of 2630/100 000 [95% confidence interval (CI): 1210-5620]. One incidental ITP case occurred after 21 months of follow-up. After a follow-up of 681.3 patient-years, the crude incidence of ITP in MGUS was 146.8 per 100 000 patient-year (95% CI: 3.7-817.8). Overall, these observations point to an association between MGUS and ITP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17535272     DOI: 10.1111/j.1365-2141.2007.06633.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

Authors:  Niels W C J van de Donk; Antonio Palumbo; Hans Erik Johnsen; Monika Engelhardt; Francesca Gay; Henrik Gregersen; Roman Hajek; Martina Kleber; Heinz Ludwig; Gareth Morgan; Pellegrino Musto; Torben Plesner; Orhan Sezer; Evangelos Terpos; Anders Waage; Sonja Zweegman; Hermann Einsele; Pieter Sonneveld; Henk M Lokhorst
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

2.  Management of immune thrombocytopoenia in a patient with newly-diagnosed smouldering myeloma and colorectal cancer.

Authors:  Agostina Siniscalchi; Roberto Stasi; Stefano Fratoni; Paolo de Fabritiis; Tommaso Caravita
Journal:  BMJ Case Rep       Date:  2009-06-11

3.  Renal thrombotic microangiopathies/thrombotic thrombocytopenic purpura in a patient with primary Sjögren's syndrome complicated with IgM monoclonal gammopathy of undetermined significance.

Authors:  Tomohiro Koga; Satoshi Yamasaki; Hideki Nakamura; Atsushi Kawakami; Akira Furusu; Takashi Taguchi; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2010-07-22       Impact factor: 2.631

Review 4.  Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.

Authors:  Louis-Pierre Girard; Cinnie Yentia Soekojo; Melissa Ooi; Wee Joo Chng; Sanjay de Mel
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

5.  Refractory immune thrombocytopenic purpura associated with IgM monoclonal gammopathy of undetermined significance: Successful treatment with tirabrutinib plus conventional therapies.

Authors:  Ryosuke Naka; Hitomi Kaneko; Osamu Nagata; Kohei Tada; Masaharu Tashima; Chisato Mizutani; Kazunori Imada
Journal:  EJHaem       Date:  2022-03-17

6.  False positive immunoassay for heparin-induced thrombocytopenia in the presence of monoclonal gammopathy: a case report.

Authors:  Ivana Markovic; Zeljko Debeljak; Bojana Bosnjak; Maja Marijanovic
Journal:  Biochem Med (Zagreb)       Date:  2017-10-15       Impact factor: 2.313

Review 7.  Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.

Authors:  Jonas Paludo; Stephen M Ansell
Journal:  F1000Res       Date:  2017-12-18

Review 8.  Longitudinal extensive transverse myelitis with an abnormal uFLC ratio in a pediatric patient: Case report and literature review.

Authors:  Po-Chang Hsu; Shyi-Jou Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

9.  Immune thrombocytopenia in myeloid and lymphoid clonal disorders: an intriguing association.

Authors:  Francesco Rodeghiero
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.